4

PRIMARY DOCUMENT

Company: AXIM BIOTECHNOLOGIES, INC.
Filed: December 30, 2015
Period of Report: April 23, 2015
Accession Number: 0001078782-15-002095

View Document ↗ View on SEC.gov ↗